CLINICAL_TRIALS
trial_result
· 2025-08-15
Clinical Trial Update: Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease [Phase 2]
Summary
Open-label extension trial for PTI-125 (simufilam) in mild-to-moderate Alzheimer's disease has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cassava Sciences, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-08-15